Newly Developed Antimicrobial Peptide May Protect from Lethal Bacterial Infections
In a new study researchers from Japan suggest that a synthetic antimicrobial peptide identified as L5 may prevent death in mice suffering from life-threatening bacterial infections, such as MRSA, by activating the host immune response. They report their findings in the June 2009 issue of the journal Antimicrobial Agents and Chemotherapy.
Innate immunity, the universal defense system shared by all animals, activates when the body responds to foreign pathogens at an early stage of infection. Cationic antimicrobial peptides (known for their antibacterial, antifungal, antiviral, antiprotozoal and antiseptic properties) are part of the innate immune response which kills microorganisms.
In a previous study researchers developed the cationic antimicrobial peptide L5 out of antibacterial proteins from Sarcophaga peregrina and found it to be an effective prophylactic treatment of MRSA in infected mice. In this study mice were administered intra-abdominal implantation as well as normal injections of L5 and observed for its ability to prevent death when challenged with lethal bacterial infections. Results showed that treatments with L5 were highly effective in preventing death when inoculated with Staphylococcus aureus Smith, Enterococcus faecalis SR1004, and Escherichia coli EC14. More specifically, normal injections of L5 prior to infection greatly reduced rates of death and intra-abdominal administration of L5 increased antibacterial activity in the abdominal cavity.
"In conclusion, we found that L5 induced the activation of the host immune responses and protected the mice from death due to infection," say the researchers. "We propose a novel therapeutic intervention that activates the host immunity in infectious diseases and has an advantage in treatment of antibiotic-resistant bacterial infection."
Newsletter
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.
New Study Explores Oral Vancomycin to Prevent C difficile Recurrence, But Questions Remain
July 17th 2025A new clinical trial explores the use of low-dose oral vancomycin to prevent Clostridioides difficile recurrence in high-risk patients taking antibiotics. While the data suggest a possible benefit, the findings stop short of statistical significance and raise red flags about vancomycin-resistant Enterococcus (VRE), underscoring the delicate balance between prevention and antimicrobial stewardship.
What Lies Beneath: Why Borescopes Are Essential for Verifying Surgical Instrument Cleanliness
July 16th 2025Despite their smooth, polished exteriors, surgical instruments often harbor dangerous contaminants deep inside their lumens. At the HSPA25 and APIC25 conferences, Cori L. Ofstead, MSPH, and her colleagues revealed why borescopes are an indispensable tool for sterile processing teams, offering the only reliable way to verify internal cleanliness and improve sterile processing effectiveness to prevent patient harm.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.
